Einige in internationalen begutachteten Fachzeitschriften veröffentlichte Artikel:
1) Altun R, Gökmen A, Tek İ, Akçağlayan Soydan E, Yüksel Kurt M. Endoscopic Evaluation of Acute Intestinal Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation . Turk J Gastroenterol 2016 Epub.
2) Aktas C, Kurtman C, Ozbilgin MK, Tek I, Toprak SK. An Experimental Study of Radiation Effect on Normal Tissue: Analysis of HIF-1?, VEGF, eIF2, TIA-1, and TSP-1 Expression. Turk J Hematol 2013; 30(4):371-78.
3) Tek I, Toprak SK, Hasdemir E, Rahatli S, Yesilkaya A. Influence of febrile neutropenia period on plasma viscosity at malignancy. ScientificWorldJournal. 2013 Oct 27;2013:507270. doi: 10.1155/2013/507270
4) Tek I, Mızrak D, Utkan G, Toprak SK, Tutkak H, Büyükçelik A, Yalçın B, Akbulut H, İçli F. IgA lambda oligoclonal gammopathy in multiple myeloma. Turk J Hematol 2010; 27(2):126-27.
5) Tek I, Iyidir OT, Utkan G, Ceyhan K, Buyukcelik A, Yalcin B, Demirkazik A. Lung Cancer Metastasis Mimicking Gluteal Abscess; Case Report. South Med J, 100,334-5 (2007).
6) Utkan G, Tek I, Kocer M, Muallaoglu S, Durnali AG, Arslan UY, Celenkoglu G, Tokluoglu S, Alkis N. Blood viscosity in patients with diffuse large B cell non-hodgkin’s lymphoma. Exp Oncol, 28, 326-327 (2006).
7) Dogan M, Demirkazik A, Konuk N, Yalcin B, Buyukcelik A, Utkan G, Tek I, Akbulut H, Sencan O, Icli F. The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospectivematched-paired study. Int J Biol Markers, 21, 206-210 (2006).
8) Utkan G, Buyukcelik A, Yalcin B, Tek I, Doruk H, Dincol D, Erekul S, Baykara M. Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia. South Med J, 99, 1149-1150 (2006).
9) Yalcin B, Dogan M, Buyukcelik A, Doruk H, Tek I, Demirkazik A. Interferon-alpha as maintenance therapy in patients with multiple myeloma. Ann Oncol, 16, 1981(2005).
10) Tek I, Büyükcelik A, Yalcin B, Akbulut H. Lymphoscintigraphy in pregnant patients with breast cancer: is it really safe? Ann Oncol, 16, 674-5 (2005).
Unser Arzt ist außerdem Mitglied der Gesellschaft der Fachärzte für Innere Medizin,
der Türkischen Onkologiegruppe,
der Gesellschaft für Medizinische Onkologie,
der Türkischen Gesellschaft für Hämatologie,
der Gesellschaft für Hämapherese,
und der Akademischen Gesellschaft für Geriatrie.